Cargando…

New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist

Detalles Bibliográficos
Autor principal: Koshak, Emad A.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883200/
https://www.ncbi.nlm.nih.gov/pubmed/20582170
http://dx.doi.org/10.4103/1817-1737.62468
_version_ 1782182241446658048
author Koshak, Emad A.
author_facet Koshak, Emad A.
author_sort Koshak, Emad A.
collection PubMed
description
format Text
id pubmed-2883200
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28832002010-06-25 New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist Koshak, Emad A. Ann Thorac Med Editorial Medknow Publications 2010 /pmc/articles/PMC2883200/ /pubmed/20582170 http://dx.doi.org/10.4103/1817-1737.62468 Text en © Annals of Thoracic Medicine http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Koshak, Emad A.
New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist
title New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist
title_full New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist
title_fullStr New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist
title_full_unstemmed New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist
title_short New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist
title_sort new fda safety warnings for labas: a call for asthma guidelines revisit for solo beta agonist
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883200/
https://www.ncbi.nlm.nih.gov/pubmed/20582170
http://dx.doi.org/10.4103/1817-1737.62468
work_keys_str_mv AT koshakemada newfdasafetywarningsforlabasacallforasthmaguidelinesrevisitforsolobetaagonist